Your email has been successfully added to our mailing list.

×
0 0 0 0 -0.0193704600484262 -0.0193704600484262 0.00726392251815987 -0.0290556900726393
Stock impact report

Oxford Biomedica notes Axovant’s positive six-month follow-up from second cohort of SUNRISE-PD Phase 2 trial of AXO-Lenti-PD

Orchard Therapeutics plc - American Depositary Shares (ORTX) 
Last orchard therapeutics plc - american depositary shares earnings: 2/27 07:00 am Check Earnings Report
Company Research Source: GlobeNewswire
Oxford Biomedica notes Axovant’s positive six-month follow-up from second cohort of SUNRISE-PD Phase 2 trial of AXO-Lenti-PD           Oxford, UK – 6 October, 2020: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), a leading gene and cell therapy group, notes Axovant Gene Therapies’ (“Axovant”) positive six-month follow-up data from the second cohort of the SUNRISE-PD Phase 2 trial of AXO-Lenti-PD gene therapy in Parkinson’s disease. Key highlights from the follow-up data were as follows: AXO-Lenti-PD was well-tolerated with no treatment-related serious adverse events at 6 months21-point mean improvement in UPDRS Part III “OFF” score, a 40% improvement from baseline based on the two evaluable patients in the study, exceeding predefined criteria for successGreater than 2-hour improvement from baseline in both diary “good ON time” and diary OFF time assessmentsEXPLORE-PD, a randomised, sham-controlled study of AXO-Lenti-PD is expected to begin dosing in 2021 To vie Show less Read more
Impact Snapshot
Event Time:
ORTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ORTX alerts
Opt-in for
ORTX alerts

from News Quantified
Opt-in for
ORTX alerts

from News Quantified